Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Pearson 2011 Statutory Pre-tax Profit Up - Quick Facts

Pearson Plc's (PSON.L,PSO: Quote) full-year 2011 statutory pre-tax profit advanced to 1.15 billion pounds from 670 million pounds in 2010, while profit attributable to equity holders of the company declining to 957 million pounds from prior year's 1.30 billion pounds.

Statutory earnings per share for the full year were 119.3 pence, considerably lower than 161.5 pence a year earlier. However, on an adjusted basis, earnings per share grew to 86.5 pence from 77.5 pence last year.

On a headline basis, sales on continuing operations totaled 5.86 billion pounds, a 4% increase from 5.66 billion pounds a year earlier. Sales, on an underlying basis, rose by 1% in 2011 versus 2010.

Click here to receive FREE breaking news email alerts for Pearson PLC and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Computer and printer maker Hewlett-Packard Co. said Tuesday after the markets closed that its fourth quarter profit fell 6% from last year, as revenue declined 2%. The company's quarterly earnings per share, excluding items, came in line with analysts' expectations, but its quarterly revenue fell short of analysts' forecast. This organic and natural products company has experienced strong compounded annual growth over the last four fiscal years with its net sales growing 25% and adjusted income from continuing operations over 30%. Here is a quick summary of the earnings reported after the bell on Nov. 24. 1. Amira Nature Foods Ltd (ANFI) reported net income for the second quarter of $8.3 million or $0.29 per share, compared to $5.0 million or $0.18 per share for the year-ago quarter. Excluding items, adjusted earnings...
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.